JJIJ

Johnson & Johnson Innovation - JJDC Portfolio holdings

AUM $978M
This Quarter Return
-41.36%
1 Year Return
+101.76%
3 Year Return
5 Year Return
10 Year Return
AUM
$184M
AUM Growth
+$184M
Cap. Flow
+$39M
Cap. Flow %
21.2%
Top 10 Hldgs %
99.79%
Holding
12
New
1
Increased
Reduced
Closed

Top Buys

1
MGTX icon
MeiraGTx Holdings
MGTX
$39M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 99.5%
2 Technology 0.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$93.8M 51.06% 3,260,869
MGTX icon
2
MeiraGTx Holdings
MGTX
$587M
$39M 21.2% +2,898,550 New +$39M
PTGX icon
3
Protagonist Therapeutics
PTGX
$3.67B
$17.3M 9.41% 2,449,183
PHGE icon
4
BiomX
PHGE
$14.3M
$14.9M 8.13% 2,133,402
PRVB
5
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$10.4M 5.63% 1,124,973
PHAS
6
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$5.32M 2.89% 1,607,044
ALDX icon
7
Aldeyra Therapeutics
ALDX
$351M
$1.47M 0.8% 594,834
CSLT
8
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$587K 0.32% 811,295
SENS icon
9
Senseonics Holdings
SENS
$374M
$333K 0.18% 525,632
GYRE icon
10
Gyre Therapeutics
GYRE
$703M
$293K 0.16% 66,951
GNCA
11
DELISTED
Genocea Biosciences, Inc.
GNCA
$248K 0.14% 143,964
TCON
12
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$143K 0.08% 84,003